SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-06-30 was $68.25K.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-03-31 was $53.50K.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-09-30 was $1.62M, a 277.81% increase year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-09-30 was $429.31K, a 27.05% decline year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2024 was $1.95M.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2022 was $1.20M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2025-06-30 | $68.25K 10-Q · filed 2026-09-24 | |
| 2025-03-31 | $53.50K 10-Q · filed 2026-09-24 | |
| 2024-12-31 | $1.95M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $1.62M 10-Q · filed 2024-11-13 | |
| 2023-09-30 | $429.31K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $2.16M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $104.55K 10-Q · filed 2023-08-14 | |
| 2022-12-31 | $1.20M 10-K/A · filed 2024-09-04 | |
| 2022-09-30 | $588.52K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |